文蛤生物体及内脏中弧菌的研究  

Research on Vibrio in Organism and Internal Organs in Meretrix meretrix Linnaeus

作　　者：黄玉柳[1] 叶欣宇[1] 黄国秋[1] 黎小正[1] 吴祥庆[1] 谢宗升[1] 陈静[1] 

机构地区：[1]广西水产研究所,广西南宁530021

出　　处：《安徽农业科学》2011年第34期21057-21058,共2页Journal of Anhui Agricultural Sciences

摘　　要：[目的]鉴定文蛤体内弧菌的类型及致病性强度,并筛选治疗这些病原菌的最佳药物。[方法]用TCBS培养基从文蛤生物体内分离出12株弧菌,对其进行致病性试验,对致病性较强的3株弧菌进行鉴定及药物敏感试验。[结果]该3株菌分别为河流弧菌H04(Vibrio fluvialis),H06副溶血弧菌(Vibrio parahaemolyticus),H11创伤弧菌(Vibrio vulnificus),其对环丙沙星、先锋赛高度敏感,对青霉素G、先锋霉素V有耐药性,临床上可以首选环丙沙星、先锋赛作为治疗这些病原菌的药物,其次是头孢曲松、氟哌酸、丁胺卡那、四环素、庆大霉素等。[结论]结果为文蛤疾病的防治提供了理论依据。[Objective] The study aimed to identify the type and pathogenic intensity of the vibrio in Meretrix meretrix Linnaeus and screen the best drugs for the treatment of the pathogenic bacterium.[Method] 12 strains of the vibrio were isolated from the organism of M.meretrix on the TCBS medium.They were made for the pathogenicity tests and 3 strains of the vibrio with stronger pathogenicity were made for the identification and the drug sensitivity test.[Result] 3 strains of the vibrio were H04 Vibrio fluvialis,H06 Vibrio parahaemolyticus and H11 Vibrio vulnificus.They were highly sensitive to the ciprofloxacin and pioneer and resistant to the penicillin G and the pioneer V.The ciprofloxacin and pioneer could be the first clinical use for the treatment of these pathogenic bacterium,followed by the ceftriaxone,norfloxacin,amikacin,minocycline and gentamycin,etc.[Conclusion] The study provided the theoretical basis for the prevention of the diseases of M.meretrix.

关 键 词：文蛤 弧菌 致病性 药敏 

分 类 号：Q959[生物学—动物学]